Literature DB >> 29443031

Ultrasound Cyclo Plasty in Eyes with Glaucoma.

Giuseppe Giannaccare1, Stefano Sebastiani2, Emilio C Campos2.   

Abstract

Glaucoma is a chronic disease caused by the progressive degeneration of the optical nerve fibers, resulting in decreased visual field that can lead to severe visual impairment, and eventually blindness. This manuscript describes a simple, surgeon-friendly, non-incisional technique, named Ultrasound Cyclo Plasty (UCP), for reducing intraocular pressure (IOP) in glaucoma patients. The technique determines a selective coagulation necrosis of the ciliary body; in addition, the stimulation of supra-choroidal and trans-scleral portions of the uveo-scleral outflow pathway has been recently proposed. UCP shows several technical improvements in ultrasound technology compared to previous techniques, providing more precise focusing on the target zone. The procedure is performed in the operating room under peribulbar anesthesia. Briefly, the coupling cone is put in contact with the eye and the ring probe, that contains six piezoelectric transducers which produce the ultrasound beams, is inserted inside it. Their proper centering over the ocular surface represents a crucial step for the correct targeting of the ciliary body. Sterile balanced salt solution is used to fill the empty spaces to ensure ultrasound acoustic propagation. Surgical treatment consists in the sequential automatic activation of each of the six transducers, for a total duration of less than 3 min. The patient leaves the hospital 1 h after the procedure with the treated eye patched. In the present study, 10 patients with open-angle glaucoma were followed-up during at least 12 months after the procedure. IOP was reduced at each interval compared to pre-operative, as well as the number of hypotensive medications. Twenty percent of patients did not respond to the treatment, and needed subsequent surgery to better control IOP. Treatment tolerability was good, with no cases of hypotony or phthisis. The UCP procedure is simpler, faster, safer, and less invasive than traditional cyclodestructive procedures with similar results in reducing IOP.

Entities:  

Mesh:

Year:  2018        PMID: 29443031      PMCID: PMC5908701          DOI: 10.3791/56192

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  28 in total

1.  Histologic effects of a new device for high-intensity focused ultrasound cyclocoagulation.

Authors:  Florent Aptel; Thomas Charrel; Xavier Palazzi; Jean-Yves Chapelon; Philippe Denis; Cyril Lafon
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-05-19       Impact factor: 4.799

2.  Uveo-scleral outflow pathways after ultrasonic cyclocoagulation in refractory glaucoma: an anterior segment optical coherence tomography and in vivo confocal study.

Authors:  Rodolfo Mastropasqua; Luca Agnifili; Vincenzo Fasanella; Lisa Toto; Lorenza Brescia; Silvio Di Staso; Emanuele Doronzo; Giorgio Marchini
Journal:  Br J Ophthalmol       Date:  2016-02-16       Impact factor: 4.638

3.  Miniaturized high-intensity focused ultrasound device in patients with glaucoma: a clinical pilot study.

Authors:  Florent Aptel; Thomas Charrel; Cyril Lafon; Fabrice Romano; Jean-Yves Chapelon; Esther Blumen-Ohana; Jean-Philippe Nordmann; Philippe Denis
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-11-11       Impact factor: 4.799

4.  Treatment of refractory open-angle glaucoma using ultrasonic circular cyclocoagulation: a prospective case series.

Authors:  Florent Aptel; Caroline Dupuy; Jean-François Rouland
Journal:  Curr Med Res Opin       Date:  2014-04-16       Impact factor: 2.580

5.  Direct costs of glaucoma and severity of the disease: a multinational long term study of resource utilisation in Europe.

Authors:  C E Traverso; J G Walt; S P Kelly; A H Hommer; A M Bron; P Denis; J-P Nordmann; J-P Renard; A Bayer; F Grehn; N Pfeiffer; C Cedrone; S Gandolfi; N Orzalesi; C Nucci; L Rossetti; A Azuara-Blanco; A Bagnis; R Hitchings; J F Salmon; G Bricola; P M Buchholz; S V Kotak; L M Katz; L R Siegartel; J J Doyle
Journal:  Br J Ophthalmol       Date:  2005-10       Impact factor: 4.638

6.  Long-term outcome of initial ciliary ablation with contact diode laser transscleral cyclophotocoagulation for severe glaucoma. The Diode Laser Ciliary Ablation Study Group.

Authors:  O Kosoko; D E Gaasterland; I P Pollack; C L Enger
Journal:  Ophthalmology       Date:  1996-08       Impact factor: 12.079

7.  Treatment of glaucoma with high intensity focused ultrasound.

Authors:  Florent Aptel; Cyril Lafon
Journal:  Int J Hyperthermia       Date:  2014-12-19       Impact factor: 3.914

8.  High-intensity focused ultrasound treatment in patients with refractory glaucoma.

Authors:  Giuseppe Giannaccare; A Vagge; C Gizzi; A Bagnis; S Sebastiani; C Del Noce; M Fresina; C E Traverso; E C Campos
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-12-03       Impact factor: 3.117

9.  Long-term outcome of trans-scleral diode laser cyclophotocoagulation in refractory glaucoma.

Authors:  M E Iliev; S Gerber
Journal:  Br J Ophthalmol       Date:  2007-05-10       Impact factor: 4.638

10.  Health-related quality of life in patients with primary open-angle glaucoma. An Italian multicentre observational study.

Authors:  Irene Floriani; Luciano Quaranta; Eliana Rulli; Andreas Katsanos; Luigi Varano; Paolo Frezzotti; Gemma C M Rossi; Luciana Carmassi; Teresa Rolle; Roberto Ratiglia; Stefano Gandolfi; Maurizio Fossarello; Maurizio Uva; Lital Hollander; Davide Poli; Federico Grignolo
Journal:  Acta Ophthalmol       Date:  2015-11-19       Impact factor: 3.761

View more
  2 in total

1.  Efficacy and safety of high-intensity focused ultrasound cyclo-plasty in glaucoma.

Authors:  Di Chen; Xiu-Juan Guo; Shu-Ke Luo; Yan Lu; Xiu-Rong Tang
Journal:  BMC Ophthalmol       Date:  2022-10-07       Impact factor: 2.086

2.  A Comparative Study between Ultrasound Cycloplasty and Cyclocryotherapy for the Treatment of Neovascular Glaucoma.

Authors:  Wang Ruixue; Wang Tao; Li Ning
Journal:  J Ophthalmol       Date:  2020-01-22       Impact factor: 1.909

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.